Prevalence and Molecular Characteristics Based on Whole Genome Sequencing of Mycobacterium tuberculosis Resistant to Four Anti-Tuberculosis Drugs from Southern Xinjiang, China

Infection and Drug Resistance - Tập Volume 14 - Trang 3379-3391
Aiketaguli Anwaierjiang1, Quan Wang2, Haican Liu3, Chunjie Yin1, Miao Xu2, Machao Li3, Mengwen Liu1, Yan Liu2, Xiuqin Zhao3, Jinbao Liu1, Guilian Li3, Xiaokaiti Mijiti2, Kanglin Wan3
1College of Public Health, Xinjiang Medical University, Wulumuqi, 830011, People's Republic of China
2The Eighth Affiliated Hospital of Xinjiang Medical University, Wulumuqi, 830001, People's Republic of China
3State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, People’s Republic of China

Tóm tắt

Từ khóa


Tài liệu tham khảo

MacNeil, 2020, MMWR Morb Mortal Wkly Rep, 69, 281, 10.15585/mmwr.mm6911a2

World Health Organization. Global Tuberculosis Report 2020. Geneva: World Health Organization, Licence: CC BY-NC-SA 30 IGO; 2020.

Wang L, Chen Sh, Zhao Y, et al. The fifth China national epidemiology of tuberculosis survey 2010. Chin J Antituberculos. 2012;34(8):485–508.

Duan, 2016, PLoS One, 11, e0148041, 10.1371/journal.pone.0148041

Wan, 2020, Infect Dis Poverty, 9, 38, 10.1186/s40249-020-00652-z

Wan, 2020, Front Microbiol, 11, 1444, 10.3389/fmicb.2020.01444

Rabahi, 2020, Infect Gene Evol, 85, 104550, 10.1016/j.meegid.2020.104550

Li, 2020, Front Microbiol, 11, 781, 10.3389/fmicb.2020.00781

Li, 2020, Infect Drug Resist, 13, 4091, 10.2147/IDR.S270209

Eddabra, 2020, Interdiscip Perspect Infect Dis, 2020, 5185896, 10.1155/2020/5185896

Unissa, 2016, Infect Genet Evol, 45, 474, 10.1016/j.meegid.2016.09.004

Chen, 2016, J Antibiot (Tokyo), 69, 149, 10.1038/ja.2015.106

Zhou, 2011, Microb Drug Resist, 17, 275, 10.1089/mdr.2010.0135

Luo, 2019, Sci Rep, 9, 7315, 10.1038/s41598-019-43547-2

Farhat, 2016, Am J Respir Crit Care Med, 194, 621, 10.1164/rccm.201510-2091OC

Miotto, 2017, Eur Respir J, 50, 1701354, 10.1183/13993003.01354-2017

Li, 2010, Biomed Environ Sci, 23, 188, 10.1016/S0895-3988(10)60051-7

Satta, 2018, Clin Microbiol Infect, 24, 604, 10.1016/j.cmi.2017.10.030

Coll, 2015, Genome Med, 7, 51, 10.1186/s13073-015-0164-0

Aubry, 2014, PLoS One, 9, e95083, 10.1371/journal.pone.0095083

CLSI. Susceptibiliy testing of mycbacteria, Nocardia spp., and other aerobic actinomycetes. 3rd ed. In: CLSI Standard M24. Wayne, PA: Cinical and Laboratory Standards Institute; 2018.

Mvelase, 2019, Open Forum Infect Dis, 6, ofz065, 10.1093/ofid/ofz065

Ali, 2015, PLoS One, 10, e0117771, 10.1371/journal.pone.0117771

Kardan-Yamchi, 2020, J Clin Med, 9, 465, 10.3390/jcm9020465

World health organization. Updated Interim Critical Concentrations for First-Line and Second-Line DST (As for May 2012). World Health Organization; 2012.

Honoré-Bouakline, 2003, J Clin Microbiol, 41, 2323, 10.1128/JCM.41.6.2323-2329.2003

Hasman, 2014, J Clin Microbiol, 52, 139, 10.1128/JCM.02452-13

Kamerbeek, 1997, J Clin Microbiol, 35, 907, 10.1128/jcm.35.4.907-914.1997

Qi, 2012, PLoS One, 7, e32103, 10.1371/journal.pone.0032103

Zhao, 2012, N Engl J Med, 366, 2161, 10.1056/NEJMoa1108789

Yuan, 2016, Infect Dis, 48, 108, 10.3109/23744235.2015.1087649

Pang, 2012, PLoS One, 7, e32976, 10.1371/journal.pone.0032976

Wang, 2015, Med Sci Monit, 21, 1313, 10.12659/MSM.892951

Pang, 2012, PLoS One, 7, e32976, 10.1371/journal.pone.0032976

Zhao, 2019, Infect Drug Resist, 12, 2457, 10.2147/IDR.S209971

Zhao, 2014, Antimicrob Agents Chemother, 58, 3475, 10.1128/AAC.02426-14

Genestet, 2020, Int J Antimicrob Agents, 55, 105912, 10.1016/j.ijantimicag.2020.105912

Campbell, 2011, Antimicrob Agents Chemother, 55, 2032, 10.1128/AAC.01550-10

Isakova, 2018, BMC Microbiol, 18, 22, 10.1186/s12866-018-1168-x

Machado, 2012, PLoS One, 7, e34538, 10.1371/journal.pone.0034538

Rodrigues, 2013, Antimicrob Agents Chemother, 57, 751, 10.1128/AAC.01482-12

Islam, 2020, Microb Drug Resist, 26, 766, 10.1089/mdr.2019.0245

Madrazo-Moya, 2019, PLoS One, 14, e0213046, 10.1371/journal.pone.0213046

Wu, 2020, Int J Infect Dis, 96, 48, 10.1016/j.ijid.2020.04.039

Al-Mutairi, 2020, Eur J Med Res, 25, 14, 10.1186/s40001-020-00412-7

Chen, 2019, Front Microbiol, 10, 1741, 10.3389/fmicb.2019.01741

Zhao, 2015, Diagn Microbiol Infect Dis, 83, 150, 10.1016/j.diagmicrobio.2015.06.020

Jagielski, 2014, PLoS One, 9, e100078, 10.1371/journal.pone.0100078

Zhao, 2015, Antimicrob Agents Chemother, 59, 2045, 10.1128/AAC.04933-14

Khosravi, 2019, Infect Drug Resist, 12, 579, 10.2147/IDR.S196800

Mohammadi, 2020, Int J Prev Med, 11, 112, 10.4103/ijpvm.IJPVM_114_19

Allix-Béguec, 2018, N Engl J Med, 379, 1403, 10.1056/NEJMoa1800474

Madison, 2002, J Clin Microbiol, 40, 3976, 10.1128/JCM.40.11.3976-3979.2002

Zhang, 2009, Chin J Zoonoses, 25, 1049

Bakuła, 2013, Biomed Res Int, 2013, 167954, 10.1155/2013/167954

Papaventsis, 2017, Clin Microbiol Infect, 23, 61, 10.1016/j.cmi.2016.09.008